When a company gets bought out, investors generally expect a premium on their stake — maybe 15 or 20 percent, sometimes more. A month after Beaverton-based Merix Corp. agreed to sell itself to a ...

The privately held company Viasystems announced that they had made a deal to merge with Merix this month. Both of the companies make printed circuit boards for a variety of applications. Viasystems is ...

Viasystems Group Inc. has agreed to become publicly traded via a reverse merger with fellow printed circuit board maker Merix Corp. (Nasdaq: MERX). Viasystems shareholders HM Capital and GSC Partners ...

Whether you're buying your first share or investing for the long-haul, we have you covered. Delivered Mondays.

Troubled Forest Grove circuit-board maker Merix Corp., facing widening losses in recent months, said Tuesday it would merge with a competitor, St. Louis-based Viasystems, Inc. The merger, when closed, ...

Rising interest rates, persistent inflation, and concern that the economy is slowing are among the factors pressuring both bonds and equities this year. One way of looking at that scenario is as an ...

Viasystems Group Inc. is acquiring rival circuit-board maker Merix Corp. in an all stock deal that will make Viasystems a public company. Merix shares tumbled 81 cents, or 29.4 percent, to $1.95 in ...

A two-year effort by Merix Corp. to increase its focus on aerospace and defense markets is starting to bear fruit. But officials with the Beaverton-based maker of printed circuit boards believe its ...

BEAVERTON, Ore.BEAVERTON, Ore. — Circuit-board maker Merix Corp., of Beaverton, Ore., will merge with Viasystems Group Inc., a St. Louis-based competitor. The companies said Tuesday that the merger ...

Under normal market conditions, the fund invests at least 80% of its total assets principally in the common stock, preferred stock and, occasionally, warrants of companies which are involved in ...

DURHAM … The scientific team that started Merix Bioscience has created a new company built on a platform of developing blood thinners and other drugs whose effects ...

DURHAM, N.C.--(BUSINESS WIRE)--Aug. 11, 2004--Merix Bioscience, a company pioneering therapeutic immunotherapy vaccines, announced today that Lothar Finke, M.D., and Doug Winship, vice president of ...